Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
9Customers
2Debt Items
12Related Chains
Source-Backed Evidence Depth
uniQure N.V. (QURE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
14Total relationships
2Distinct source URLs
5High confidence
0.734Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
uniQure N.V. Suppliers
Ticker
Name
Confidence
Evidence
GENEZEN
GENEZEN
90%
Pursuant to the CSA, Genezen manufactures and supplies CSL Behring’s commercial demand for HEMGENIX® on our behalf.
Reciprocal relationship from MGX graph: evenue and achieve or maintain profitability; • the level of taxes that we are required to pay; and • the availability of capital. Any reduction in reimburseme…
uniQure N.V. Customers
Ticker
Name
Confidence
Evidence
CSL-BEHRING
CSL-BEHRING
90%
We are contractually obligated to supply the Product until such time that these capabilities are transferred to CSL Behring or its designated contract manufacturing organization.
Reciprocal relationship from MGX graph: evenue and achieve or maintain profitability; • the level of taxes that we are required to pay; and • the availability of capital. Any reduction in reimburseme…
COMPANY-INCORPORATED
COMPANY-INCORPORATED
62%
t we own or have licensed may be held invalid or unenforceable, as a result of legal challenges by our competitors; ● our competitors might conduct activities in countries where we do not have patent…
CSL-BEHRING-INC
CSL-BEHRING-INC
62%
2.5 million (presented within Other expense in the Consolidated Statement of Operations and Comprehensive Loss) was recorded during the year ended December 31, 2024. 131 Table of Contents The Com…
CSL-BEHRING-LLC
CSL-BEHRING-LLC
62%
6: PSUs Weighted average Number of grant-date fair ordinary shares value Non-vested at December 31, 2025 22,500 $ 15.40 Granted — $ — Vested — …
GENEZEN-HOLDINGS-INC
GENEZEN-HOLDINGS-INC
62%
maining employees terminated effective August 30, 2024. uniQure Inc. and uniQure B.V., both wholly owned subsidiaries of the Company, entered into an APA with Genezen on June 29, 2024. Pursuant to …
GENEZEN-MA-INC
GENEZEN-MA-INC
62%
6: PSUs Weighted average Number of grant-date fair ordinary shares value Non-vested at December 31, 2025 22,500 $ 15.40 Granted — $ — Vested — …
GUGGENHEIM-SECURITIES-LLC
GUGGENHEIM-SECURITIES-LLC
62%
t we own or have licensed may be held invalid or unenforceable, as a result of legal challenges by our competitors; ● our competitors might conduct activities in countries where we do not have patent…
LEERINK-PARTNERS-LLC
LEERINK-PARTNERS-LLC
62%
t we own or have licensed may be held invalid or unenforceable, as a result of legal challenges by our competitors; ● our competitors might conduct activities in countries where we do not have patent…
uniQure N.V. Debt Obligations
Instrument
Description
Confidence
Evidence
QURE-DEBT
Debt stack $61.1M
90%
Market cache reports total debt of $61.1M.
QURE-DEBT-12027
Warrants outstanding: 12
90%
xbrl warrant detail from xbrl 2025-12-31.
uniQure N.V. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for uniQure N.V..
uniQure N.V. Ownership
Holder
Name
Confidence
Evidence
QURE-OWNER-AVORO-CAPITAL-ADVISORS-LLC
Avoro Capital Advisors LLC
90%
13F overlay lists Avoro Capital Advisors LLC as top holder; 222 tracked holders.
